Keyphrases
Herpes Simplex Virus Infection
100%
Aciclovir
100%
Antibody-based Immunotherapy
100%
Ocular Herpes
100%
Monoclonal Antibody
66%
Acute Retinal Necrosis
50%
Health Problems
16%
Therapeutic Potential
16%
Mouse Model
16%
Blindness
16%
Developed Countries
16%
Pre-exposure Prophylaxis (PrEP)
16%
Herpes Simplex Virus 2 (HSV-2)
16%
Increased Incidence
16%
Microinjection
16%
Resistant Strains
16%
Balb C Mice
16%
Glycoprotein B
16%
Retinal Damage
16%
Resistant Infection
16%
Anterior Chamber of the Eye
16%
Pharmacology, Toxicology and Pharmaceutical Science
Herpes Simplex Virus
100%
Virus Infection
100%
Aciclovir
100%
Immunotherapy
100%
Monoclonal Antibody
66%
Necrosis
50%
Infection
33%
Mouse Model
16%
Bagg Albino Mouse
16%
Human Alphaherpesvirus 1
16%
Retina Injury
16%
Glycoprotein B
16%
Diseases
16%
Immunology and Microbiology
Viral Disease
100%
Monoclonal Antibody
100%
Herpes Simplex Virus
100%
Immunotherapy
100%
Infection
50%
Anterior Eye Chamber
25%
Mouse Model
25%
Glycoprotein
25%
Human Alphaherpesvirus 1
25%
Bagg Albino Mouse
25%
Microinjection
25%
Neuroscience
Aciclovir
100%
Immunotherapy
100%
Herpes Simplex Virus
100%
Monoclonal Antibody
66%
Necrosis
50%
Glycoprotein B
16%